T2 Biosystems, Inc. (TTOO)

T2 Biosystems Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-45.65	-50.08	-62.33	-49.24	-46.8	-59.01
Depreciation & Amortization	2.06	2.21	2.27	2.54	3.16	3.64
Share-Based Compensation	4.11	4.35	6.49	7.09	3.91	5.46
Other Operating Activities	-7.4	-4.62	2.61	0.74	-3.49	4.55
Operating Cash Flow	-46.88	-48.14	-50.63	-38.87	-43.22	-45.36
Capital Expenditures	-0.07	-0.19	-0.34	-0.46	-0.8	-0.76
Change in Investments	0	0	10	25.25	-35.46	0
Investing Cash Flow	-0.07	-0.19	9.66	24.79	-36.26	-0.76
Share Issuance / Repurchase	43.1	52.75	29.08	20.54	85.61	7.23
Debt Issued / Paid	0	0	0	0	0	-0.88
Other Financing Activities	-0.06	-0.06	-0.03	-	-	-
Financing Cash Flow	43.04	52.69	29.05	20.54	85.61	6.35
Net Cash Flow	-3.91	4.36	-11.92	6.45	6.13	-39.77
Free Cash Flow	-46.95	-48.33	-50.97	-39.33	-44.02	-46.12
Free Cash Flow Margin	-654.28%	-671.88%	-228.50%	-140.19%	-242.77%	-553.35%
Free Cash Flow Per Share	-9.21	-18.52	-999.31	-1238.00	-1813.83	-5067.49

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).